Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Bulaksumur, Yogyakarta 55281, Indonesia.
Research Center for Biotechnology, Research Organization for Life Sciences, National Research and Innovation Agency (BRIN), Jalan Raya Jakarta-Bogor KM. 46, Cibinong 16911, Indonesia.
Molecules. 2022 Feb 9;27(4):1178. doi: 10.3390/molecules27041178.
An antiviral agent is urgently needed based on the high probability of the emergence and re-emergence of future viral disease, highlighted by the recent global COVID-19 pandemic. The emergence may be seen in the discovery of the Alpha, Beta, Gamma, Delta, and recently discovered Omicron variants of SARS-CoV-2. The need for strategies besides testing and isolation, social distancing, and vaccine development is clear. One of the strategies includes searching for an antiviral agent that provides effective results without toxicity, which is well-presented by significant results for carrageenan nasal spray in providing efficacy against human coronavirus-infected patients. As the primary producer of sulfated polysaccharides, marine plants, including macro- and microalgae, offer versatility in culture, production, and post-isolation development in obtaining the needed antiviral agent. Therefore, this review will describe an attempt to highlight the search for practical and safe antiviral agents from algal-based sulfated polysaccharides and to unveil their features for future development.
鉴于未来病毒性疾病的出现和再现的高概率,急需一种抗病毒药物,最近的全球 COVID-19 大流行就凸显了这一点。这种出现可能表现在发现 SARS-CoV-2 的 Alpha、Beta、Gamma、Delta 和最近发现的 Omicron 变体中。除了测试和隔离、社交距离和疫苗开发之外,还需要有其他策略。其中一种策略包括寻找一种没有毒性但效果显著的抗病毒药物,卡拉胶鼻喷雾剂在为感染人类冠状病毒的患者提供疗效方面就表现出了显著的效果。作为硫酸多糖的主要生产者,包括大型和微型藻类在内的海洋植物在培养、生产和分离后开发方面具有多功能性,可获得所需的抗病毒药物。因此,本综述将尝试强调从藻类来源的硫酸多糖中寻找实用且安全的抗病毒药物,并揭示其未来发展的特点。